Correlation Between Rasna Therapeutics and Cell Source

Can any of the company-specific risk be diversified away by investing in both Rasna Therapeutics and Cell Source at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rasna Therapeutics and Cell Source into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rasna Therapeutics and Cell Source, you can compare the effects of market volatilities on Rasna Therapeutics and Cell Source and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rasna Therapeutics with a short position of Cell Source. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rasna Therapeutics and Cell Source.

Diversification Opportunities for Rasna Therapeutics and Cell Source

0.08

Correlation Coefficient

Rasna Therapeutics  Cell Source

Significant diversification

The 3 months correlation between Rasna and Cell is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Rasna Therapeutics and Cell Source in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Source and Rasna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rasna Therapeutics are associated (or correlated) with Cell Source. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Source has no effect on the direction of Rasna Therapeutics i.e., Rasna Therapeutics and Cell Source go up and down completely randomly.

Pair Corralation between Rasna Therapeutics and Cell Source

Given the investment horizon of 90 days Rasna Therapeutics is expected to generate 10.48 times more return on investment than Cell Source. However, Rasna Therapeutics is 10.48 times more volatile than Cell Source. It trades about 0.11 of its potential returns per unit of risk. Cell Source is currently generating about 0.1 per unit of risk. If you would invest  0.40  in Rasna Therapeutics on May 5, 2025 and sell it today you would earn a total of  0.00  from holding Rasna Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Rasna Therapeutics  vs.  Cell Source

Rasna Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Rasna Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Rasna Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Cell Source

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cell Source are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cell Source unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rasna Therapeutics and Cell Source

The main advantage of trading using opposite Rasna Therapeutics and Cell Source positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rasna Therapeutics position performs unexpectedly, Cell Source can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Source will offset losses from the drop in Cell Source's long position.

The idea behind Rasna Therapeutics and Cell Source pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.